leadf
logo-loader
viewEXMceuticals

EXMceuticals settles $4.6 million loan through share issuance

CEO Jonathan Summers acquired 11.3 million shares by way of a private placement, representing around 16.4% of the Vancouver-based company

EXMceuticals -
The shares were acquired at a price of C$0.20 per share

EXMceuticals Inc (CSE:EXM) said it has settled a C$4.6 million loan by issuing just over 23 million shares of the bio-science company.

As part of the loan settlement, CEO Jonathan Summers acquired 11.3 million shares by way of a private placement, representing around 16.4% of the Vancouver-based company.

Summers now owns around 16.5% of EXMceuticals’ 68.8 million outstanding shares on an undiluted basis and just over 18.4 million or 24.3% on a partially diluted basis.

READ: EXMceuticals raises over $1 million in new financing, strengthens balance sheet with debt to equity conversion

Also as part of the loan settlement, shareholder Michael Cohen acquired nearly 6.3 million shares via a private placement and now owns around 9.1% of EXMceutical shares on an undiluted basis. Cohen now owns about 7.6 million shares or around 11.1% of the firm’s outstanding shares on an undiluted basis.

The shares were acquired at a price of C$0.20 per share for a total value of nearly $2.3 million in the case of Summers and $1.25 million in Cohen’s case.

In a statement, EXMceuticals said that Summers and Cohen “(have) no present intention to dispose of or acquire further securities of the company.”

The firm recently added another $1 million to its balance sheet with a debt-to-equity conversion.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: EXMceuticals

Price: 0.19 CAD

CSE:EXM
Market: CSE
Market Cap: $7.51 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

EXMceuticals now '100% focused on being a refining bioscience business in...

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development. Summers explains that the company has recently transitioned from being active in Africa to focusing their attentions solely onto Portugal. The company...

5 days, 3 hours ago

2 min read